ClinicalTrials.gg
Sign In

Insulin Resistance clinical trials

The registry lists 2,969 studies for Insulin Resistance across more than 10 countries. 338 are recruiting or about to start. 713 of them are mainly about Insulin Resistance (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its narrower condition Metabolic Syndrome too: 4,764 studies, 640 open.

ClinicalTrials.gov finds 5,081 studies for Insulin Resistance. How that becomes 2,966 here

This page counts the studies the registry files under Insulin Resistance, and those it files under no condition that list Insulin Resistancethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 5,081Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,775Filed under a narrower condition, counted on its own pageMetabolic Syndrome 1,775
  3. −4List Insulin Resistance as a condition, but the registry did not file them under itMost often written as “Systemic Insulin Resistance” (1), “Type 2 Diabetes Mellitus With Features of Insulin Resistance” (1), and “Obesity-Associated Insulin Resistance” (1). The registry filed them under other conditions only, most often Diabetes Mellitus, Type 2 (2) and Non-alcoholic Fatty Liver Disease (1).
  4. −336Match it another way267 name it in the title, 10 in a keyword, and 59 by a synonym or other text the search reads.
  5. 2,966The count on this page5 of them list Insulin Resistance in their own words; the registry filed them under no condition.

Get an email when these change. Save the Insulin Resistance studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
2,019
Status unknown
297
Recruiting
244
Terminated
136
Active, not recruiting
85
Withdrawn
83

Phase

Phase 2
336
Phase 4
285
Phase 3
178
Phase 1
176
Early Phase 1
42

Where

United States
1,117
Canada
197
Denmark
149
United Kingdom
105
Netherlands
100
Germany
92

Who runs them

University of Aarhus (45) · Massachusetts General Hospital (44) · Maastricht University Medical Center (44) · University of Copenhagen (37) · Pennington Biomedical Research Center (35) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (35) · Stanford University (33) · University of Alabama at Birmingham (27)

What is being tested here

Drugs under test in Insulin Resistance studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Metformin825120
Insulin81184
Semaglutide8611
Insulin, Regular, Human4329
Empagliflozin4410
Tirzepatide404
Pioglitazone2547
Glucagon2114
Human Growth Hormone2012
Probiotic207

Drug classes tested here GLP-1 receptor agonists 13 open · SGLT2 inhibitors 4 open · Corticosteroids 2 open · DPP-4 inhibitors 1 open · Diuretics 1 open

Coming up

19phase 3 studies under way
128studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 244 Insulin Resistance studies recruiting now, 54 (22%) set no upper age limit and 158 (65%) stop at 75 or younger. 30 (12%) take children under 18. 42 (17%) are for women only and 3 (1%) for men only; 113 (46%) take healthy volunteers.

Recruiting studies that take each age, of 244
AgeWomenMen
1016 (7%)13 (5%)
18162 (66%)136 (56%)
30191 (78%)159 (65%)
40198 (81%)164 (67%)
50175 (72%)154 (63%)
65158 (65%)139 (57%)
75104 (43%)89 (36%)
8568 (28%)54 (22%)

Across all 2,969 studies, recruiting or not: 70% stop at 75 or younger and 53% at 65; 13% take children; 13% are for women only and 9% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Insulin Resistance studies take

Of 73 phase 4 interventional studies under Insulin Resistance, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 124 mo13–67 · 65 studies—26 mo14–80 · 51 studies
Phase 245 mo25–64 · 59 studies—46 mo27–65 · 49 studies
Phase 2/318 mo10–53 · 15 studies——
Phase 328 mo17–53 · 44 studies——
Phase 421 mo9–44 · 73 studies—29 mo9–57 · 63 studies
Interventional, no phase21 mo9–40 · 754 studies9 mo3–22 · 40 studies22 mo10–41 · 714 studies
Observational53 mo18–143 · 133 studies—53 mo18–142 · 130 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting4

Results posted2

Stopped2

Newly registered8

Show 3 more

Studies

Recruiting first, then most recently updated. Showing 50 of 2,969. Browse all 2,969 → or search them.